These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29664198)

  • 1. Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy.
    Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Roback JD; Fasano RM
    Transfusion; 2018 Jun; 58(6):1363-1371. PubMed ID: 29664198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
    Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Fasano RM
    Transfusion; 2017 Nov; 57(11):2738-2746. PubMed ID: 28840600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease.
    Sagiv E; Fasano RM; Luban NLC; Josephson CD; Stowell SR; Roback JD; Francis RO; Yee MEM
    Am J Hematol; 2018 May; 93(5):630-634. PubMed ID: 29377292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease.
    Yee ME; Francis RO; Luban NLC; Easley KA; Lough CM; Roback JD; Josephson CD; Fasano RM
    Transfusion; 2022 Mar; 62(3):551-555. PubMed ID: 35044697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
    Leal I; Dos Santos TD; Gilli S; Castilho L
    Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
    Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS
    Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).
    Lasalle-Williams M; Nuss R; Le T; Cole L; Hassell K; Murphy JR; Ambruso DR
    Transfusion; 2011 Aug; 51(8):1732-9. PubMed ID: 21332724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
    Israelyan N; Vege S; Friedman DF; Zhang Z; Uter S; Fasano RM; Yee M; Piccone C; Kelly S; Hankins JS; Zheng Y; Westhoff CM; Chou ST
    Transfusion; 2024 Mar; 64(3):526-535. PubMed ID: 38289184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
    Campbell-Lee SA; Gvozdjan K; Choi KM; Chen YF; Saraf SL; Hsu LL; Gordeuk VR; Strauss RG; Triulzi DJ
    Transfusion; 2018 Jul; 58(7):1588-1596. PubMed ID: 29570817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.
    McPherson ME; Anderson AR; Castillejo MI; Hillyer CD; Bray RA; Gebel HM; Josephson CD
    Pediatr Blood Cancer; 2010 Apr; 54(4):552-8. PubMed ID: 19890898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.
    Nickel RS; Horan JT; Fasano RM; Meyer E; Josephson CD; Winkler AM; Yee ME; Kean LS; Hendrickson JE
    Am J Hematol; 2015 Dec; 90(12):1135-41. PubMed ID: 26361243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
    Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC
    Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do I incorporate red cell genotyping to improve chronic transfusion therapy?
    Van Buren NL; Gorlin JB; Corby SM; Cassidy S; FritchLilla S; Nelson SC; Westhoff CM
    Transfusion; 2020 Jan; 60(1):16-25. PubMed ID: 31758587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interval decline in hemoglobin A is associated with annual clinical event rate in sickle cell anemia patients receiving maintenance apheresis RBC exchange.
    Kamyszek RW; Raval JS; Srinivasan AJ; Ansari AK; Evans BA; Rollins-Raval MA; Poisson JL; Shah NR; Welsby IJ
    Transfusion; 2019 Aug; 59(8):2622-2628. PubMed ID: 31161685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease.
    Yee MEM; Covington ML; Zerra PE; McCoy JW; Easley KA; Joiner CH; Bryksin J; Francis RO; Lough CM; Patel N; Kutlar A; Josephson CD; Roback JD; Stowell SR; Fasano RM
    Transfusion; 2024 Jun; 64(6):1109-1115. PubMed ID: 38693059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
    Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT
    Br J Haematol; 2015 Jul; 170(2):247-56. PubMed ID: 25891976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood.
    Raciti PM; Francis RO; Spitalnik PF; Schwartz J; Jhang JS
    J Clin Apher; 2013 Aug; 28(4):325-9. PubMed ID: 23450789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.